DANIELLE SEINER: Open Payments
NPI 1851737225 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 37 payments from 15 companies in 2025. Trend: 2023 $308 · 2024 $617 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $193 |
| ABBVIE INC. | 4 | $73 |
| Eisai Inc. | 3 | $64 |
| Novo Nordisk Inc | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Alkermes, Inc. | 2 | $34 |
| Globus Medical, Inc. | 1 | $33 |
| Radius Health, Inc. | 1 | $32 |
Products named: MOUNJARO, Leqembi, KISUNLA, QULIPTA, Veozah, CAPLYTA, ARISTADA, Senza.
Industry payments across MO — which companies pay providers there.
